Table 1.
Baseline Demographic and Clinical Characteristics
| Breast Cancer (n = 223) | Control (n = 126) | P Value | |
|---|---|---|---|
| Age at baseline, y | 55.6 ± 10.9 | 50.6 ± 14.1 | <0.001 |
| Race | 0.73 | ||
| White | 172 (77) | 101 (80) | |
| Black | 38 (17) | 18 (14) | |
| Other, Asian, Native Hawaiian, or not reported | 13 (6) | 7 (6) | |
| Ethnicity | 0.80 | ||
| Hispanic or LatinX | 2 (1) | 2 (2) | |
| Stage at breast cancer diagnosis | |||
| I | 85 (38) | ||
| II | 115 (52) | ||
| III | 23 (10) | ||
| Anthracyclines | 109 (49) | ||
| Body mass index, kg/m2 | 29.4 ± 6.2 | 28.4 ± 6.8 | 0.19 |
| History of hypertension | 61 (31) | 18 (21) | 0.13 |
| History of hyperlipidemia | 66 (33) | 27 (31) | 0.57 |
| History of coronary artery disease | 1 (1) | 1 (1) | 0.67 |
| History of diabetes | 16 (8) | 5 (6) | 0.63 |
Values are the mean ± SD or n (%).
Medical history included 199 participants in the breast cancer group and 88 participants in the control group.